TRHC Tabula Rasa HealthCare, Inc. Stock Quote

TRHC [NASD]

Healthcare | Health Information Services | USA

Index	-	P/E	-	EPS (ttm)	-3.69	Insider Own	7.90%	Shs Outstand	22.55M	Perf Week	-14.92%
Market Cap	865.26M	Forward P/E	76.50	EPS next Y	0.45	Insider Trans	-11.79%	Shs Float	22.34M	Perf Month	-35.95%
Income	-81.00M	PEG	-	EPS next Q	-0.08	Inst Own	-	Short Float	22.03%	Perf Quarter	-1.09%
Sales	297.20M	P/S	2.91	EPS this Y	-136.00%	Inst Trans	0.92%	Short Ratio	11.01	Perf Half Y	-33.70%
Book/sh	7.47	P/B	4.62	EPS next Y	143.78%	ROA	-16.70%	Target Price	48.71	Perf Year	-36.82%
Cash/sh	0.93	P/C	36.98	EPS next 5Y	33.00%	ROE	-47.20%	52W Range	30.12 - 69.31	Perf YTD	-19.47%
Dividend	-	P/FCF	508.98	EPS past 5Y	-35.00%	ROI	-13.90%	52W High	-50.22%	Beta	0.96
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	33.50%	Gross Margin	31.10%	52W Low	14.54%	ATR	3.96
Employees	1614	Current Ratio	1.30	Sales Q/Q	5.30%	Oper. Margin	-22.00%	RSI (14)	25.12	Volatility	6.48% 7.71%
Optionable	Yes	Debt/Eq	1.58	EPS Q/Q	-316.60%	Profit Margin	-27.20%	Rel Volume	2.05	Prev Close	35.06
Shortable	Yes	LT Debt/Eq	1.48	Earnings	Feb 23 AMC	Payout	-	Avg Volume	446.76K	Price	34.50
Recom	2.60	SMA20	-27.56%	SMA50	-28.49%	SMA200	-26.78%	Volume	900,478	Change	-1.60%

Mar-01-21

Downgrade

Truist

Buy → Hold

$41 → $42

Feb-25-21

Downgrade

Piper Sandler

Overweight → Neutral

$40 → $41

Jan-15-21

Downgrade

Stifel

Buy → Hold

$52

Nov-04-20

Reiterated

The Benchmark Company

Buy

$65 → $55

Jul-02-20

Initiated

SunTrust

Buy

$72

Apr-21-20

Initiated

RBC Capital Mkts

Outperform

$70

Apr-13-20

Initiated

SVB Leerink

Outperform

Aug-30-19

Upgrade

Stifel

Hold → Buy

$50 → $75

Apr-18-19

Initiated

Guggenheim

Neutral

Jan-08-19

Initiated

The Benchmark Company

Buy

$85

Nov-07-18

Reiterated

Chardan Capital Markets

Buy

$77 → $91

Sep-07-18

Initiated

Cantor Fitzgerald

Overweight

May-18-18

Reiterated

Chardan Capital Markets

Buy

$50 → $68

Mar-16-18

Reiterated

Chardan Capital Markets

Buy

$46 → $50

Mar-13-18

Reiterated

Oppenheimer

Outperform

$35 → $47

Dec-11-17

Initiated

William Blair

Outperform

Sep-07-17

Reiterated

Chardan Capital Markets

Buy

$21 → $45

Sep-07-17

Downgrade

Wells Fargo

Outperform → Market Perform

Aug-30-17

Reiterated

UBS

Buy

$18 → $25

Aug-08-17

Reiterated

Chardan Capital Markets

Buy

$19.50 → $21

Feb-24-21 02:30PM	Tabula Rasa HealthCare, Inc. (TRHC) Q4 2020 Earnings Call Transcript Motley Fool
08:45AM	Tabula Rasas 4Q Sales Beat Estimates; Street Sees 18% Upside SmarterAnalyst
06:30AM	Tabula Rasa Healthcare, Inc. to Host Earnings Call ACCESSWIRE
Feb-23-21 09:42PM	Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results PR Newswire
08:00AM	Tabula Rasa HealthCare and ASHP Partner to Facilitate Use of MedWise Software, Improve the Safe Use of Medications in Health Systems PR Newswire
Feb-22-21 08:00AM	Tabula Rasa HealthCare to Provide Innovative Medication Risk Mitigation Technology to National Primary Care Network MDVIP PR Newswire
Feb-16-21 08:15AM	PrimeRx and Tabula Rasa HealthCare Now Offer Integration Technology for Automated COVID-19 Vaccine Reporting PR Newswire
Feb-11-21 08:00AM	Tabula Rasa HealthCare Fourth Quarter and Full Year 2020 Earnings Conference Call Announcement PR Newswire
Feb-03-21 08:00AM	Tabula Rasa HealthCare Deploys MedWise Risk Score Technology to PrescribeWellness Community Pharmacy Network PR Newswire
Jan-28-21 08:00AM	Tabula Rasa HealthCare Partners with RxResults to Provide Pharmacy Risk Management for Health Plans PR Newswire -12.29%
Jan-27-21 05:22AM	Is There Now An Opportunity In Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)? Simply Wall St. +5.68%
Jan-19-21 08:00AM	American Society of Health-System Pharmacists and Tabula Rasa HealthCare Partner to Offer Vancomycin Bayesian Dosing Solution for Members PR Newswire
Jan-11-21 08:00AM	Tabula Rasa HealthCare and Innovative Integrated Health Community Plans, Inc. Collaborate to Build Medicare Advantage Program PR Newswire
Dec-29-20 08:00AM	Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference GlobeNewswire
Dec-17-20 09:30AM	TRHCs DoseMeRx® Partners with Physiomics to Provide Precision Dosing for Oncology Medications GlobeNewswire
Dec-12-20 04:02PM	Is TRHC A Good Stock To Buy Now? Insider Monkey
Dec-10-20 08:00AM	Tabula Rasa HealthCare Signs Agreement with Missouri Pharmacy Association to Provide Medication Safety Technology Education to Members GlobeNewswire
Nov-30-20 08:00AM	Tabula Rasa HealthCare Names Celynda G.Tadlock, PharmD, MBA, Chief Client Officer and EVP of Pharmacy Benefit Services GlobeNewswire
Nov-25-20 03:40AM	What Can We Learn About Tabula Rasa HealthCare's (NASDAQ:TRHC) CEO Compensation? Simply Wall St. -5.81%
Nov-24-20 08:00AM	American Academy of Home Care Medicine Partners with Tabula Rasa HealthCare to Offer Online Clinical Documentation Education for Members GlobeNewswire
Nov-19-20 08:00AM	Tabula Rasa HealthCare Partners with Heritage Health Solutions to Expand Enhanced Medication Therapy Management Services to Self-insured Employers GlobeNewswire
Nov-16-20 08:45AM	TRHC Forms a Strategic Alliance with the American College of Apothecaries (ACA) to Market TRHC Solutions to Members GlobeNewswire
Nov-12-20 08:00AM	Neil Medical Group Selects TRHCs DoseMeRx to Provide Precision Dosing Services For Long-term Care Facilities GlobeNewswire
Nov-09-20 11:40AM	CPSI vs. TRHC: Which Stock Is the Better Value Option? Zacks
Nov-04-20 06:45AM	Tabula Rasa Healthcare, Inc. to Host Earnings Call ACCESSWIRE -16.26%
Nov-03-20 05:55PM	Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Lags Revenue Estimates Zacks +8.93%
04:30PM	Tabula Rasa HealthCare Reports Third Quarter 2020 Results GlobeNewswire
Nov-02-20 08:00AM	Tabula Rasa HealthCare and PioneerRx to Partner to Deploy MedWise Medication Safety Software Technology to PioneerRx Community Pharmacies GlobeNewswire
Oct-22-20 08:00AM	Tabula Rasa HealthCare Third Quarter 2020 Earnings Conference Call Announcement GlobeNewswire
Oct-15-20 09:43AM	Tabula Rasa HealthCare and the American Pharmacists Association Launch Medication Safety Campaign GlobeNewswire
Oct-05-20 07:00AM	Tabula Rasa HealthCare Expands CareVention HealthCare Offerings with the Addition of PersonifilRx and Pharmastar GlobeNewswire
Sep-30-20 08:00AM	Tabula Rasa HealthCare Announces Strategic Partnership with Direct Scripts to Provide Medication Therapy Management using MedWise to Self-insured Employer Markets GlobeNewswire
Sep-25-20 11:40AM	NXGN or TRHC: Which Is the Better Value Stock Right Now? Zacks +5.43%
Sep-17-20 08:00AM	Tabula Rasa HealthCare Supports Legislation Establishing Medication Risk Prevention Program for NJ Medicaid GlobeNewswire
Sep-15-20 02:38PM	Introducing Tabula Rasa HealthCare (NASDAQ:TRHC), A Stock That Climbed 59% In The Last Three Years Simply Wall St.
Sep-14-20 08:44AM	Tabula Rasa HealthCare and Medplus Solutions form Partnership to Bring MedWise Medication Safety Solutions to Puerto Rico GlobeNewswire
Sep-09-20 11:40AM	NXGN vs. TRHC: Which Stock Is the Better Value Option? Zacks
08:00AM	TRHC Announces Three Key Executive Hires GlobeNewswire
Aug-24-20 11:40AM	NXGN vs. TRHC: Which Stock Should Value Investors Buy Now? Zacks
Aug-19-20 08:00AM	Pack4U Selects SinfoniaRx, a Tabula Rasa HealthCare solution, for Clinical Telepharmacy Services to Improve Medication Adherence and Outcomes for Patients GlobeNewswire
Aug-12-20 11:02AM	Results of Tabula Rasa HealthCares First Simulated Clinical Study on Proposed COVID-19 Treatments and Therapies is Published GlobeNewswire
Aug-06-20 08:00AM	TRHCs CareVention HealthCare Partners with Golden Valley Health Centers to Provide Multiple Services to new Central Valley PACE program GlobeNewswire
Aug-04-20 11:05PM	Tabula Rasa Healthcare (TRHC) Q2 Earnings Top Estimates Zacks -6.03%
05:17PM	Tabula Rasa HealthCare Reports Second Quarter 2020 Results GlobeNewswire
Jul-28-20 12:33PM	Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-22-20 10:14AM	Tabula Rasa HealthCare Second Quarter 2020 Earnings Conference Call Announcement GlobeNewswire
Jul-16-20 11:40AM	CERN vs. TRHC: Which Stock Should Value Investors Buy Now? Zacks
Jul-15-20 08:00AM	Tabula Rasa HealthCare Launches MedWise SaaS Technology Integration for Community Pharmacists GlobeNewswire +6.16%
Jul-06-20 08:56AM	Tabula Rasa HealthCare (TRHC) in Focus: Stock Moves 5.2% Higher Zacks
Jun-30-20 11:40AM	CERN or TRHC: Which Is the Better Value Stock Right Now? Zacks
Jun-29-20 08:08AM	Tabula Rasa HealthCares Risk Adjustment Division Launches New Online Training for Physicians and Other Providers GlobeNewswire
Jun-25-20 08:00AM	Tabula Rasa HealthCare® Expands Clinical Services for Patients Enrolled in Medicare Advantage GlobeNewswire
Jun-16-20 08:00AM	TRHC and Equiscript Launch an Advanced Medication Adherence Reporting and Analytics Program GlobeNewswire
Jun-14-20 09:34PM	Hedge Funds Warming Up To Tabula Rasa HealthCare, Inc. (TRHC) Insider Monkey
Jun-09-20 08:00AM	Regence and TRHC partner on COVID-19 virtual clinical trial to assess proposed treatment risks GlobeNewswire
Jun-03-20 01:07PM	Tabula Rasa Healthcare Reaches 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Jun-02-20 03:39PM	Meet The Innovative Psychedelics Incubator By Tabula Rasa Ventures Benzinga
May-27-20 08:00AM	TRHCs MedWise Risk Score Reduces the Odds of Adverse Drug Events, Keeping Patients Safer GlobeNewswire +7.30%
May-20-20 10:20AM	Is Now An Opportune Moment To Examine Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)? Simply Wall St.
May-19-20 08:00AM	TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource GlobeNewswire
May-18-20 11:40AM	HMSY or TRHC: Which Is the Better Value Stock Right Now? Zacks
May-12-20 11:00AM	Was The Smart Money Right About Tabula Rasa HealthCare, Inc. (TRHC)? Insider Monkey -5.09%
May-11-20 08:00AM	TRHC and ASCP Sign Letter of Intent to offer MedWise to Consultant Pharmacists GlobeNewswire
May-09-20 11:30AM	Tabula Rasa HealthCare, Inc. Common Stock (TRHC) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 06:35PM	Tabula Rasa Healthcare (TRHC) Q1 Earnings Match Estimates Zacks
05:12PM	Tabula Rasa HealthCare Reports First Quarter 2020 Results GlobeNewswire
May-04-20 08:00AM	TRHC and Speed Script Expand Partnership for Clinical Documentation GlobeNewswire -6.45%
Apr-30-20 12:34PM	Tabula Rasa Healthcare (TRHC) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
11:40AM	CPSI vs. TRHC: Which Stock Should Value Investors Buy Now? Zacks
Apr-29-20 12:10PM	Why Tabula Rasa Healthcare (TRHC) is Poised to Beat Earnings Estimates Again Zacks
07:55AM	TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments GlobeNewswire
Apr-23-20 05:05PM	Tabula Rasa HealthCare to Release First Quarter 2020 Operating Results May 7, 2020 GlobeNewswire
08:00AM	Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar GlobeNewswire
Apr-22-20 11:08AM	Zacks.com featured highlights include: Ionis Pharmaceuticals, Aphria, Tabula Rasa Healthcare, InterDigital and Huron Consulting Group Zacks
Apr-21-20 08:00AM	Tabula Rasa HealthCares DoseMeRx Integrates with The Sanford Guide GlobeNewswire
07:09AM	Grab 5 Top Stocks With Strong Earnings Beat Prospects Zacks
Apr-16-20 08:11AM	Tabula Rasa HealthCare® and CQuentia® Expand Partnership with COVID-19 Test Kit Distribution Agreement GlobeNewswire
Apr-14-20 02:48PM	Does Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Salary Reflect Performance? Simply Wall St. +6.36%
Apr-13-20 12:04PM	Tabula Rasa partnership to provide COVID-19 test kits to thousands of pharmacies American City Business Journals
08:12AM	TRHC Provides COVID-19 Testing Opportunities to Community Pharmacies Across the United States GlobeNewswire
Apr-07-20 08:00AM	EPIC Pharmacy Network Renews Contract with TRHCs PrescribeWellness® GlobeNewswire
Apr-02-20 08:00AM	VigiLanz® Announces Precision Dosing Powered by Tabula Rasa HealthCares DoseMeRx GlobeNewswire
Mar-26-20 01:00PM	Tabula Rasa HealthCare® Names Frank Sparacino SVP Investor Relations and Corporate Development GlobeNewswire
Mar-25-20 11:30AM	Is Tabula Rasa Healthcare (TRHC) Stock Outpacing Its Medical Peers This Year? Zacks
Mar-24-20 08:17AM	Tabula Rasa HealthCare® is Providing Programs of All-Inclusive Care for the Elderly (PACE) Access to COVID-19 Testing Kits GlobeNewswire +18.81%
Mar-19-20 08:00AM	2020 Women on Boards Honors Tabula Rasa HealthCare for Having at Least 20% Women on its Corporate Board GlobeNewswire
Mar-18-20 01:52PM	South Jersey health tech company signs deal to distribute patient-monitoring 'stickers' American City Business Journals
Mar-17-20 08:01AM	Tabula Rasa HealthCare Named Principal Distributor of the BioIntelliSense BioSticker for Programs of All-Inclusive Care for the Elderly (PACE) GlobeNewswire +14.42%
Feb-27-20 04:05PM	Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2019 Results GlobeNewswire -10.29%
Feb-20-20 12:31PM	Earnings Preview: Tabula Rasa Healthcare (TRHC) Q4 Earnings Expected to Decline Zacks
Feb-19-20 11:02AM	Medical Software Firm Tabula Rasa Earns 95-Plus Composite Rating Investor's Business Daily
Feb-18-20 08:00AM	TRHC Signs Agreement to Provide CareVention HealthCare® Services to New PACE Organization GlobeNewswire
Feb-06-20 08:30AM	Tabula Rasa Healthcare to Announce Fourth Quarter and Full Year 2019 Operating Results and Host Conference Call on Thursday, February 27, 2020 GlobeNewswire
Jan-27-20 08:57AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tabula Rasa HealthCare, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire
Jan-24-20 10:28AM	What Kind Of Share Price Volatility Should You Expect For Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)? Simply Wall St. -7.28%
Jan-21-20 10:00AM	Tabula Rasa HealthCare to Host Investor and Analyst Day on January 29, 2020 GlobeNewswire
Jan-13-20 08:00AM	Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020 GlobeNewswire
Dec-19-19 04:41PM	Should You Buy Tabula Rasa HealthCare, Inc. (TRHC)? Insider Monkey
08:25AM	Tabula Rasa HealthCare (NASDAQ:TRHC) Shareholders Have Enjoyed An Impressive 218% Share Price Gain Simply Wall St.
Dec-17-19 08:00AM	TRHC to Provide Clinical Pharmacy Support and Medication Management Services to CVS Pharmacy GlobeNewswire

Tabula Rasa HealthCare, Inc. provides patient-specific and data-driven technology and solutions in the field of medication safety in the United States. Its proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. The company offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. Its cloud-based software also comprise RxCompanion, an MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) organizations; and PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting. In addition, the company offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2019, it served 237 healthcare organizations. The company provides its cloud-based software solutions to prescribers, pharmacists, pharmacies, and healthcare organizations for managing the medication-related needs of patients. It has collaboration with Innovative Integrated Health Community Plans, Inc.; and RxResults. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knowlton Orsula V	President	Feb 17	Sale	48.46	24,000	1,162,921	848,332	Feb 19 04:36 PM
Knowlton Calvin H	Chief Executive Officer	Feb 17	Sale	48.46	24,000	1,162,921	852,622	Feb 19 04:37 PM
TUNSTALL GORDON	Director	Feb 10	Option Exercise	1.56	1,000	1,560	13,786	Feb 12 05:06 PM
TUNSTALL GORDON	Director	Feb 10	Sale	57.00	1,000	57,000	12,786	Feb 12 05:06 PM
Knowlton Orsula V	President	Feb 09	Sale	53.26	2,903	154,614	740,781	Feb 10 05:20 PM
Knowlton Calvin H	Chief Executive Officer	Feb 08	Sale	54.37	8,000	434,978	732,170	Feb 10 05:24 PM
Knowlton Orsula V	President	Feb 08	Sale	55.01	5,097	280,364	736,460	Feb 10 05:20 PM
Adams Brian W	Chief Financial Officer	Jan 27	Option Exercise	3.11	12,000	37,320	223,126	Jan 29 06:41 PM
Greenhalgh Michael	Chief Operating Officer	Jan 27	Option Exercise	3.11	16,000	49,760	156,646	Jan 29 06:43 PM
Greenhalgh Michael	Chief Operating Officer	Jan 27	Sale	60.00	16,000	960,000	140,646	Jan 29 06:43 PM
Adams Brian W	Chief Financial Officer	Jan 27	Sale	60.00	12,000	720,000	211,126	Jan 29 06:41 PM
Greenhalgh Michael	Chief Operating Officer	Jan 21	Option Exercise	3.11	3,000	9,330	143,646	Jan 22 06:15 PM
Greenhalgh Michael	Chief Operating Officer	Jan 21	Sale	52.20	3,000	156,600	140,646	Jan 22 06:15 PM
Knowlton Orsula V	President	Jan 19	Sale	52.23	8,000	417,808	697,585	Jan 21 05:17 PM
Knowlton Calvin H	Chief Executive Officer	Jan 19	Sale	52.23	8,000	417,808	693,295	Jan 21 05:17 PM
TUNSTALL GORDON	Director	Jan 13	Option Exercise	1.56	1,000	1,560	13,786	Jan 15 04:59 PM
TUNSTALL GORDON	Director	Jan 13	Sale	50.00	1,000	50,000	12,786	Jan 15 04:59 PM
Adams Brian W	Chief Financial Officer	Jan 12	Sale	46.35	1,809	83,847	211,126	Jan 14 04:59 PM
Greenhalgh Michael	Chief Operating Officer	Jan 12	Sale	46.35	966	44,774	140,646	Jan 14 04:53 PM
Speers Andrea Carolan	Chief Accounting Officer	Jan 12	Sale	46.35	905	41,947	27,017	Jan 14 04:50 PM
Adams Brian W	Chief Financial Officer	Jan 04	Sale	41.75	6,160	257,205	212,935	Jan 06 06:44 PM
Speers Andrea Carolan	Chief Accounting Officer	Jan 04	Sale	41.87	5,301	221,965	27,922	Jan 06 06:51 PM
Greenhalgh Michael	Chief Operating Officer	Jan 04	Sale	41.77	2,568	107,256	141,612	Jan 06 06:47 PM
Knowlton Calvin H	Chief Executive Officer	Dec 16	Sale	40.07	12,366	495,506	714,045	Dec 16 08:27 PM
Knowlton Calvin H	Chief Executive Officer	Dec 16	Sale	40.07	18,547	743,178	814,372	Dec 16 08:27 PM
Knowlton Orsula V	President	Dec 16	Sale	40.07	18,547	743,178	810,082	Dec 16 08:23 PM
Knowlton Orsula V	President	Dec 16	Sale	40.07	12,366	495,506	718,335	Dec 16 08:23 PM
Knowlton Calvin H	Chief Executive Officer	Dec 15	Sale	40.11	1,938	77,733	726,411	Dec 16 08:27 PM
Knowlton Calvin H	Chief Executive Officer	Dec 15	Sale	40.11	2,908	116,640	832,919	Dec 16 08:27 PM
Knowlton Orsula V	President	Dec 15	Sale	40.11	2,908	116,640	828,629	Dec 16 08:23 PM
Knowlton Orsula V	President	Dec 15	Sale	40.11	1,938	77,733	730,701	Dec 16 08:23 PM
Speers Andrea Carolan	Chief Accounting Officer	Dec 14	Sale	40.00	6,033	241,320	33,223	Dec 16 08:33 PM
Knowlton Calvin H	Chief Executive Officer	Dec 14	Sale	40.21	1,696	68,196	728,349	Dec 16 08:27 PM
Knowlton Calvin H	Chief Executive Officer	Dec 14	Sale	40.21	2,545	102,334	835,827	Dec 16 08:27 PM
Knowlton Orsula V	President	Dec 14	Sale	40.21	2,545	102,334	831,537	Dec 16 08:23 PM
Knowlton Orsula V	President	Dec 14	Sale	40.21	1,696	68,196	732,639	Dec 16 08:23 PM
Speers Andrea Carolan	Chief Accounting Officer	Nov 17	Sale	33.04	125	4,130	39,256	Nov 19 05:06 PM
Knowlton Calvin H	Chief Executive Officer	Oct 09	Sale	42.82	8,000	342,560	728,651	Oct 13 06:33 PM
Knowlton Orsula V	President	Oct 09	Sale	42.82	8,000	342,560	732,941	Oct 13 06:29 PM
Knowlton Calvin H	Chief Executive Officer	Sep 17	Sale	42.08	8,000	336,658	736,651	Sep 18 06:20 PM
Knowlton Orsula V	President	Sep 17	Sale	42.08	8,000	336,658	740,941	Sep 18 06:17 PM
Knowlton Orsula V	President	Sep 11	Option Exercise	8.55	10,358	88,612	832,379	Sep 15 08:31 AM
Knowlton Orsula V	President	Sep 11	Option Exercise	7.16	8,554	61,263	748,941	Sep 15 08:31 AM
Knowlton Calvin H	Chief Executive Officer	Sep 11	Option Exercise	7.16	8,554	61,263	744,651	Sep 15 08:24 AM
Knowlton Calvin H	Chief Executive Officer	Sep 11	Option Exercise	8.55	10,358	88,612	836,669	Sep 15 08:24 AM
Knowlton Orsula V	President	Sep 08	Sale	48.74	8,000	389,924	822,021	Sep 10 05:10 PM
Knowlton Calvin H	Chief Executive Officer	Sep 08	Sale	48.74	8,000	389,924	826,311	Sep 10 05:05 PM
Beckwith Samira	Director	Aug 17	Sale	45.84	2,140	98,098	8,756	Aug 19 04:24 PM
Knowlton Orsula V	President	Aug 10	Option Exercise	12.78	169,295	2,163,358	923,964	Aug 12 08:22 PM
Knowlton Orsula V	President	Aug 10	Option Exercise	3.42	36,723	125,593	756,424	Aug 12 08:22 PM
Knowlton Calvin H	Chief Executive Officer	Aug 10	Option Exercise	3.42	36,723	125,593	752,134	Aug 12 08:16 PM
Knowlton Calvin H	Chief Executive Officer	Aug 10	Option Exercise	12.78	169,295	2,163,358	928,254	Aug 12 08:16 PM
Knowlton Orsula V	President	Aug 10	Sale	48.17	8,000	385,393	719,701	Aug 11 05:42 PM
Knowlton Calvin H	Chief Executive Officer	Aug 10	Sale	48.17	8,000	385,393	715,411	Aug 11 05:37 PM
Knowlton Orsula V	President	Aug 07	Sale	49.07	8,000	392,592	754,669	Aug 11 05:42 PM
Knowlton Calvin H	Chief Executive Officer	Aug 07	Sale	49.07	8,000	392,592	758,959	Aug 11 05:37 PM
Knowlton Orsula V	President	Jul 20	Sale	58.51	8,000	468,042	727,701	Jul 22 04:29 PM
Knowlton Calvin H	Chief Executive Officer	Jul 20	Sale	58.51	8,000	468,042	723,411	Jul 22 04:25 PM
TUNSTALL GORDON	Director	Jul 08	Option Exercise	1.56	1,000	1,560	12,989	Jul 09 04:45 PM
TUNSTALL GORDON	Director	Jul 08	Sale	56.02	1,000	56,020	11,989	Jul 09 04:45 PM
Knowlton Orsula V	President	Jul 07	Sale	56.13	8,000	449,043	762,669	Jul 09 04:31 PM
Knowlton Calvin H	Chief Executive Officer	Jul 07	Sale	56.13	8,000	449,043	766,959	Jul 09 04:52 PM
Greenhalgh Michael	Chief Operating Officer	Jun 17	Option Exercise	3.11	1,000	3,110	144,684	Jun 19 05:28 PM
Greenhalgh Michael	Chief Operating Officer	Jun 17	Sale	59.25	1,000	59,250	143,684	Jun 19 05:28 PM
TUNSTALL GORDON	Director	Jun 10	Option Exercise	1.56	1,000	1,560	12,989	Jun 10 09:24 PM
TUNSTALL GORDON	Director	Jun 10	Sale	58.30	1,000	58,300	11,989	Jun 10 09:24 PM
Knowlton Orsula V	President	Jun 08	Sale	58.81	8,000	470,447	770,669	Jun 09 07:13 PM
Knowlton Orsula V	President	Jun 08	Sale	58.81	8,000	470,447	735,701	Jun 09 07:13 PM
Knowlton Calvin H	Chief Executive Officer	Jun 08	Sale	58.81	8,000	470,447	731,411	Jun 09 07:09 PM
Knowlton Calvin H	Chief Executive Officer	Jun 08	Sale	58.81	8,000	470,447	774,959	Jun 09 07:09 PM
Adams Brian W	Chief Financial Officer	Jun 05	Option Exercise	3.11	3,000	9,330	221,599	Jun 08 07:30 PM
Speers Andrea Carolan	Chief Accounting Officer	Jun 05	Sale	60.00	2,260	135,600	39,040	Jun 08 07:36 PM
Adams Brian W	Chief Financial Officer	Jun 05	Sale	60.08	3,000	180,240	218,599	Jun 08 07:30 PM
Greenhalgh Michael	Chief Operating Officer	May 27	Option Exercise	3.11	2,000	6,220	145,684	May 29 05:42 PM
Greenhalgh Michael	Chief Operating Officer	May 27	Sale	60.00	2,000	120,000	143,684	May 29 05:42 PM
Knowlton Calvin H	Chief Executive Officer	May 15	Sale	56.82	8,000	454,588	739,411	May 19 05:52 PM
Knowlton Orsula V	President	May 15	Sale	56.82	8,000	454,588	743,701	May 19 05:45 PM
TUNSTALL GORDON	Director	May 13	Option Exercise	1.56	1,000	1,560	12,989	May 14 05:40 PM
TUNSTALL GORDON	Director	May 13	Sale	55.02	1,000	55,020	11,989	May 14 05:40 PM
Knowlton Orsula V	President	May 07	Sale	60.09	8,000	480,687	783,669	May 11 06:32 PM
Knowlton Calvin H	Chief Executive Officer	May 07	Sale	60.09	8,000	480,687	787,959	May 11 06:31 PM
Adams Brian W	Chief Financial Officer	May 01	Option Exercise	3.11	3,000	9,330	221,599	May 05 05:29 PM
Adams Brian W	Chief Financial Officer	May 01	Sale	60.30	3,000	180,886	218,599	May 05 05:29 PM
Speers Andrea Carolan	Chief Accounting Officer	Apr 30	Sale	62.53	2,260	141,313	41,300	May 01 06:52 PM
Greenhalgh Michael	Chief Operating Officer	Apr 27	Option Exercise	3.11	2,000	6,220	145,684	Apr 29 05:34 PM
Greenhalgh Michael	Chief Operating Officer	Apr 27	Sale	62.55	2,000	125,100	143,684	Apr 29 05:34 PM
Adams Brian W	Chief Financial Officer	Apr 20	Option Exercise	3.11	9,559	29,728	228,158	Apr 21 04:57 PM
Adams Brian W	Chief Financial Officer	Apr 20	Sale	60.18	9,559	575,261	218,599	Apr 21 04:57 PM
Knowlton Orsula V	President	Apr 17	Sale	56.77	8,000	454,129	751,701	Apr 21 05:04 PM
Knowlton Calvin H	Chief Executive Officer	Apr 17	Sale	56.77	8,000	454,129	747,411	Apr 21 05:02 PM
Adams Brian W	Chief Financial Officer	Apr 15	Option Exercise	3.11	2,441	7,592	221,040	Apr 17 05:47 PM
Speers Andrea Carolan	Chief Accounting Officer	Apr 15	Sale	60.00	4,520	271,200	43,560	Apr 17 05:47 PM
Adams Brian W	Chief Financial Officer	Apr 15	Sale	60.09	2,441	146,680	218,599	Apr 17 05:47 PM
TUNSTALL GORDON	Director	Apr 08	Option Exercise	1.56	1,000	1,560	12,989	Apr 09 06:28 PM
TUNSTALL GORDON	Director	Apr 08	Sale	50.00	1,000	50,000	11,989	Apr 09 06:28 PM
Knowlton Calvin H	Chief Executive Officer	Apr 07	Sale	51.88	8,000	415,059	795,959	Apr 09 06:28 PM
Knowlton Orsula V	President	Apr 07	Sale	51.88	8,000	415,059	791,699	Apr 09 06:29 PM
Helling Dennis	Director	Mar 20	Option Exercise	14.00	5,000	70,000	17,847	Mar 24 04:55 PM
Helling Dennis	Director	Mar 20	Sale	45.12	5,000	225,600	12,847	Mar 24 04:55 PM
TUNSTALL GORDON	Director	Mar 19	Option Exercise	1.56	8,000	12,480	19,989	Mar 20 04:52 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience